The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
Adameová, A
The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats. [electronic resource] - Die Pharmazie Sep 2005 - 714-5 p. digital
Publication Type: Journal Article
0031-7144
Animals
Blood Glucose--metabolism
Cholesterol--blood
Cholesterol, Dietary--pharmacology
Clofibrate--analogs & derivatives
Diabetes Mellitus, Experimental--blood
Dietary Fats--pharmacology
Enzyme Inhibitors--pharmacology
Hypercholesterolemia--blood
Hypolipidemic Agents
Liver--drug effects
Rats
Rats, Wistar
Sterol O-Acyltransferase--antagonists & inhibitors
Triglycerides--blood
The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats. [electronic resource] - Die Pharmazie Sep 2005 - 714-5 p. digital
Publication Type: Journal Article
0031-7144
Animals
Blood Glucose--metabolism
Cholesterol--blood
Cholesterol, Dietary--pharmacology
Clofibrate--analogs & derivatives
Diabetes Mellitus, Experimental--blood
Dietary Fats--pharmacology
Enzyme Inhibitors--pharmacology
Hypercholesterolemia--blood
Hypolipidemic Agents
Liver--drug effects
Rats
Rats, Wistar
Sterol O-Acyltransferase--antagonists & inhibitors
Triglycerides--blood